CMS certification 210019
Tidalhealth Peninsula Regional, INC
100 East Carroll Avenue, Salisbury, MD 21801
Tidalhealth Peninsula Regional has a CMS overall rating of 4 out of 5 stars. 66% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 607 completed surveys, 19% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MD | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 344 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 57 min | 4 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 20 visits sampled | 4 h 26 min | 6 h 55 min | 4 h 17 min |
| Left before being seen Lower is better · 80,141 patients | 3% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 16 patients | 69% | 69% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 127 patients | 57% | 65% | 65% |
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,368 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 433 cases | Too few cases | 11.4% | 11.9% |
| Heart failure 649 cases | Too few cases | 10.5% | 11.1% |
| Pneumonia 748 cases | Too few cases | 17.7% | 15.2% |
| Stroke 470 cases | Too few cases | 10.5% | 11.9% |
| COPD 415 cases | Too few cases | 13% | 8.6% |
| Heart bypass surgery (CABG) 242 cases | Too few cases | 3.3% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.91 likely 0.67 – 1.15 | 1 |
| After hip or knee replacement 50 cases | Too few cases | 4.6% | 4.1% |
| Deaths after a serious but treatable surgical complication 93 cases | No different | 212.08 per 1,000 likely 167.75 per 1,000 – 256.42 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 11,319 cases | No different | 0.65 per 1,000 likely 0.13 per 1,000 – 1.16 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 12,755 cases | Worse | 0.4 per 1,000 likely 0.23 per 1,000 – 0.57 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 13,112 cases | No different | 0.3 per 1,000 likely 0.12 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,866 cases | No different | 2.04 per 1,000 likely 0.8 per 1,000 – 3.28 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,441 cases | No different | 0.93 per 1,000 likely 0 per 1,000 – 2.23 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,486 cases | No different | 11.19 per 1,000 likely 7 per 1,000 – 15.38 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,237 cases | No different | 2.58 per 1,000 likely 0.86 per 1,000 – 4.31 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,500 cases | No different | 2.86 per 1,000 likely 0 per 1,000 – 5.81 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 643 cases | No different | 1.76 per 1,000 likely 0.36 per 1,000 – 3.16 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,985 cases | No different | 0.66 per 1,000 likely 0 per 1,000 – 1.52 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.28 likely 0.07 – 0.75 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.96 likely 0.5 – 1.66 | 1 |
| Surgical site infections after colon surgery | No different | 0.84 likely 0.27 – 2.02 | 1 |
| MRSA bloodstream infections | No different | 0.79 likely 0.25 – 1.91 | 1 |
| C. diff intestinal infections | Better | 0.31 likely 0.17 – 0.53 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 427 cases | Too few cases | 14.7% | 14.4% |
| Readmitted after heart failure 792 cases | Too few cases | 18.6% | 21.3% |
| Readmitted after pneumonia 737 cases | Too few cases | 16.9% | 17.3% |
| Readmitted after COPD 414 cases | Too few cases | 18.8% | 20% |
| Readmitted after heart bypass surgery 183 cases | Too few cases | 11.7% | 11% |
| Readmitted after hip or knee replacement 37 cases | Too few cases | 5.8% | 5.8% |
| Days back in hospital after a heart attack 465 cases | Too few cases | 26.8 days per 100 | — |
| Days back in hospital after heart failure 732 cases | Too few cases | -20.5 days per 100 | — |
| Days back in hospital after pneumonia 748 cases | Too few cases | -1.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,766 cases | No different | 10.7 per 1,000 likely 8.2 per 1,000 – 13.7 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 207 cases | No different | 10.7 per 100 likely 8.2 per 100 – 13.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 207 cases | No different | 6.4 per 100 likely 4.6 per 100 – 8.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 889 cases | No different | 1 likely 0.8 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
472 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 87 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 46 |
| Physician Assistant | 37 |
| Nurse Anesthetist, Certified Registered | 31 |
| Physical Therapist | 22 |
| Physical Therapy Assistant | 22 |
| Hospitalist | 21 |
| Emergency Medicine | 19 |
| Nurse Practitioner | 18 |
| Occupational Therapist | 17 |
| Speech-Language Pathologist | 17 |
| Anesthesiology | 16 |
| Occupational Therapy Assistant | 16 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Debt forgiveness | $4,155 | 4 |
| Medical devices and supplies on long-term loan | $484 | 1 |
| Space rental and facility fees | $300 | 1 |
| Speaking, teaching and other services | $82 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Research & Development, LLC | $207,900 | 27 |
| Amgen Inc. | $100,253 | 2 |
| CathWorks, Inc. | $24,990 | 4 |
| Medtronic, Inc. | $10,479 | 16 |
| Genentech, Inc. | $4,750 | 3 |
| Aesculap, Inc. | $3,516 | 1 |
| Stryker Corporation | $628 | 2 |
| Linvatec Corporation | $484 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral … Janssen Research & Development, LLC | $190,366 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants Wi… Amgen Inc. | $59,366 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at … Amgen Inc. | $40,888 |
| ALL-RISE CathWorks, Inc. | $24,990 |
| A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) Janssen Research & Development, LLC | $13,574 |
| PSR-CVG Medtronic, Inc. | $10,479 |
| Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC Genentech, Inc. | $4,750 |
| A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial Fibrillation for Anticoagula… Janssen Research & Development, LLC | $3,960 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Tidalhealth Peninsula Regional
Is Tidalhealth Peninsula Regional a good hospital?
Tidalhealth Peninsula Regional has a CMS overall rating of 4 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Tidalhealth Peninsula Regional?
66% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 607 completed HCAHPS surveys.
How long is the wait in the Tidalhealth Peninsula Regional emergency room?
Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Tidalhealth Peninsula Regional receive money from drug and device companies?
Drug and device makers reported $353,393 in payments to Tidalhealth Peninsula Regional for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.